With Tetra Data Platform (TDP), Jounce Therapeutics saw a significant reduction in manual data intervention while enjoying easier, faster search. Benefits include improved data integrity and shifting scientists’ focus back to developing therapeutics EXECUTIVE SUMMARY Jounce Therapeutics aims to transform the treatment of cancer by developing immunotherapies that can restore, enhance, or mimic the immune system’s attack on target cells. This approach prioritizes targets and identifies related biomarkers to match the right immunotherapy to the right patients for meaningful and long-lasting benefit. To maximize the value of data generated from a wide array of scientific lab instruments and software systems, Jounce needed to take a data-centric approach to their data management. With

Join for free to read